Submit Deal

BIOTRACK CAPITAL

Summary

BioTrack Capital is a venture capital firm based in Shanghai, China. The firm is seeks to invest in healthcare and life science sectors across China.

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 787 M

Avg. Deal Size£ 157 M

Market Context

Senior Management

Feng Tao
Co-Founder & Partner
Kevin Chen
Founding Partner
Qinggang Zhuang
Executive Director

Sort

24 Jul 2020|China|Biotechnology

Target: HAIHE BIOPHARMA

Bidder: CHAOS INVESTMENT

10 Service Providers

2 Target | 8 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 134 M

Value

20 Aug 2021|China|Biotechnology

Target: ABOGEN BIOSCIENCES

Bidder: INVESCO ASSET MANAGEMENT LTD

22 Service Providers

1 Target | 21 Bidder

28 Dealmakers

2 Target | 26 Bidder

£ 520 M

Value

14 Dec 2021|Singapore|Biotechnology

Target: CARGENE

Bidder: HYFINITY INVESTMENTS

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 14 M

Value

02 Jun 2022|United States|Biotechnology

Target: NUPROBE

Bidder: ASTRAZENECA PLC

9 Service Providers

3 Target | 6 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 39 M

Value

04 Jan 2024|United States|Pharmaceuticals

Target: ONCUSP THERAPEUTICS

Bidder: NOVO HOLDINGS A/S

5 Service Providers

1 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 78 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy